These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3534742)

  • 1. [Hepatic diffusion of ceftriaxone].
    Lucht F; Tigaud S; Brun M; Mahul P; Peyramond D; Bertrand JL
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):559-60. PubMed ID: 3534742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections.
    Joos B; Luethy R; Muehlen E; Siegenthaler W
    Am J Med; 1984 Oct; 77(4C):59-62. PubMed ID: 6093521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the diffusion of ceftriaxone in digestive surgery after a single administration at doses of one and two grams].
    Lokiec F; Boudinet A; Petot P
    Pathol Biol (Paris); 1987 May; 35(5):448-50. PubMed ID: 3302845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ceftriaxone in serum and in gynecological tissues.
    Götz A; Weissenbacher ER; Gutschow K; Wachter I; Schneider A
    Acta Eur Fertil; 1987; 18(2):127-8. PubMed ID: 3630575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction.
    Wise R; Wright N
    Infection; 1985; 13 Suppl 1():S145-50. PubMed ID: 4055047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone kinetics after a single intravenous dose in leukemic children with fever and granulocytopenia.
    Rossi MR; Boccazzi A; Capuccilli ML; Crosignani R; Gornati G; Masera G
    Chemioterapia; 1986 Aug; 5(4):283-4. PubMed ID: 3464362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bronchial diffusion of ceftriaxone].
    Husson MO; Debout J; Krivosic-Horber R
    Pathol Biol (Paris); 1986 May; 34(5):325-7. PubMed ID: 3534699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of ceftriaxone (Rocephine) within the framework of preventive antibiotic therapy in digestive surgery].
    Zeyer B; Meyer C; Jenny JY; Valinos P; Hollender LF
    J Chir (Paris); 1986 Mar; 123(3):207-8. PubMed ID: 3722289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Single shot" prevention in abdominal surgery. Antibiotics with long half-life (ceftriaxone, ornidazole) vs. antibiotics with short half-life (cefazolin, metronidazole, clindamycin)].
    Schweizer W; Striffeler H; Lüdi D; Fröscher R
    Helv Chir Acta; 1994 Apr; 60(4):483-8. PubMed ID: 8034522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffusion of ceftriaxone in human bone tissue].
    Soudry B; Sirot J; Lopitaux R; Dumont C; Delisle JJ; Parenton M
    Pathol Biol (Paris); 1986 Sep; 34(7):859-62. PubMed ID: 3537931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
    Stoeckel K; Koup JR
    Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].
    Brogard JM; Jehl F; Paris-Bockel D; Sini F; Blickle JF; Adloff M; Monteil H
    Schweiz Med Wochenschr; 1987 Oct; 117(40):1549-59. PubMed ID: 3672089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diffusion of ceftriaxone into the human brain].
    Dorche G; Lucht F; Bertrand AM; Vinhas E; Gibaud H; Aubert G; Brunon J
    Pathol Biol (Paris); 1990 Jun; 38(6):638-42. PubMed ID: 2374699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of ceftriaxone in plasma and in pus in patients with soft tissue abscesses.
    Georgopoulos A; Lang F; Hölbing N; Graninger W; Breyer S; Mailer H; Probst P
    J Chemother; 1989 Jul; 1(4 Suppl):522-3. PubMed ID: 16312513
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of cimetidine in patients with liver disease.
    González-Martin G; Arancibia A; Fajuri M; Chesta J; Novoa X
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-hydroxybenzoylglycine, a drug-binding inhibitor in uremia.
    Fiset C; Vallée F; LeBel M; Bergeron MG
    Ther Drug Monit; 1986; 8(4):483-9. PubMed ID: 3824437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the activity of hepatic benzo (a) pyrene hydroxylase in human needle biopsies and the clearance of glymidine.
    Held H
    Hepatogastroenterology; 1980 Aug; 27(4):266-70. PubMed ID: 6451570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
    Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
    Gulberg V; Deibert P; Ochs A; Rossle M; Gerbes AL
    Hepatogastroenterology; 1999; 46(26):1126-30. PubMed ID: 10370679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.